FIBROSCAN-DERIVED LIVER STIFFNESS AFTER ANTIVIRAL TREATMENT FOR HEPATITIS C IS ASSOCIATED WITH LIVER CANCER, DECOMPENSATED CIRRHOSIS, AND MORTALITY

被引:0
|
作者
Vutien, Philip [1 ,2 ]
Kim, Nicole [1 ,2 ]
Moon, Andrew [3 ]
Pearson, Meredith [1 ,2 ]
Su, Feng [1 ,2 ]
Berry, Kristin [4 ]
Gelman, Hannah [4 ]
Ioannou, George [1 ,2 ]
机构
[1] Univ Washington, Med Ctr, Gastroenterol & Hepatol, Seattle, WA 98195 USA
[2] Vet Affairs Puget Sound Healthcare, Gastroenterol, Tacoma, WA USA
[3] Univ N Carolina, Gastroenterol & Hepatol, Chapel Hill, NC 27515 USA
[4] Vet Affairs Puget Sound Healthcare, Res & Dev, Tacoma, WA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
510
引用
收藏
页码:322A / 322A
页数:1
相关论文
共 50 条
  • [31] Impact of new direct-acting antiviral drugs on hepatitis C virus-related decompensated liver cirrhosis
    Essa, Mohamed
    Sabry, Aliaa
    Abdelsameea, Eman
    Tharwa, El-Sayed
    Salama, Mohsen
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 53 - 58
  • [32] Antiviral Therapy in Hepatitis B Virus-Associated Liver Cirrhosis
    Boettler, Tobias
    Thimme, Robert
    DIGESTIVE DISEASES, 2015, 33 (04) : 608 - 612
  • [33] New Prognostic Model for 1-year Mortality in patients with Decompensated Hepatitis B virus-related Liver Cirrhosis receiving antiviral treatment
    Kim, Tae Hyung
    Gu, Daehoe
    Um, Soon Ho
    Yun, Tae Jung
    Yim, Sun Young
    Seo, Yeon Seok
    Yim, Hyung Joon
    Keum, Bora
    Park, Beom Jin
    HEPATOLOGY, 2015, 62 : 911A - 911A
  • [34] A NEW PROGNOSTIC MODEL FOR 1-YEAR MORTALITY IN PATIENTS WITH DECOMPENSATED HEPATITIS B VIRUS-RELATED LIVER CIRRHOSIS RECEIVING ANTIVIRAL TREATMENT
    Kim, T. H.
    Um, S. H.
    Gu, D. H.
    Yoon, S. B.
    Yun, T. J.
    Yim, S. Y.
    Jung, J. Y.
    Seo, Y. S.
    Yim, H. J.
    Keum, B.
    Jeen, Y. T.
    Lee, H. S.
    Chun, H. J.
    Kim, C. D.
    Ryu, H. S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S567 - S567
  • [35] Does the Quality of Liver Sample Influence the Predictive Value for Fibrosis of Liver Stiffness (FibroScan®), in Chronic C Hepatitis?
    Sporea, Ioan
    Sirli, Roxana
    Deleanu, Alexandra E.
    Tudora, Adriana
    Cornianu, Marioara
    Bota, Simona I.
    GASTROENTEROLOGY, 2009, 136 (05) : A324 - A325
  • [36] Hydroxychloroquine reduces liver related mortality in hepatitis C associated (HCV) compensated cirrhosis
    Kouroumalis, EA
    Moschandreas, J
    Alexandrakis, G
    Matrella, E
    GUT, 2002, 50 : A114 - A115
  • [37] Early decrease of liver stiffness after initiation of antiviral therapy in patients with chronic hepatitis C
    Moser, Stephan
    Gutic, Enisa
    Schleicher, Michael
    Gschwantler, Michael
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (08) : 970 - 971
  • [38] DECREASE IN LIVER STIFFNESS IN CHRONIC HEPATITIS C PATIENTS AFTER DIRECT - ACTING ANTIVIRAL THERAPY
    Kainth, S.
    Jindal, A.
    Sarin, S. K.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S823 - S823
  • [39] The role of liver iron in hepatitis C antiviral treatment
    Musallam, Khaled M.
    Sharara, Ala I.
    Inati, Adlete
    Taher, Ali T.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (06) : 769 - 769
  • [40] Hepatitis C Treatment Threshold in Patients With Decompensated Liver Disease
    Suraweera, Duminda
    Saab, Sammy
    HEPATOLOGY, 2017, 65 (06) : 1789 - 1791